| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8243361 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 12 Pages |
Abstract
Conclusion: Patients in PR after six cycles of mechlorethamine, vincristine, procarbazine, prednisone/doxorubicine, bleomycine, vinblastine treated with IF-RT had 8-year event-free survival and overall survival rates similar to those of patients in CR, suggesting a definite role for RT in these patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Berthe M.P. M.D., John M.M. Ph.D., Radka M.D., Margreet H.A. M.D., Roberto M.D., Marnix L.M. M.D., Richard W.M. Ph.D., Théodore Ph.D., Geertrui M.D., Pieternella Ph.D., Yolande Ph.D., Daphne Ph.D., Antonella B.S., Michel Ph.D.,